In hemochromatosis, disruption of the hepcidin pathway due to mutations in genes encoding auxiliary factors in iron signaling to hepcidin result in insufficient hepcidin responses to iron intake or to high body iron stores. This evidence concerns the gene HAMP and hemochromatosis type 1.